MTOR and neoplasm: The mTOR inhibitor rapamycin was able to reduce both S6 phosphorylation and HIF-1α protein levels in normoxic tumor cells, suggesting that in uveal melanoma an active mTOR cascade may promote a “hypoxic” transcriptional response even in the presence of oxygen (Figure 1E).